Seres Therapeutics, Inc.

549300GMXBE5NUWISF13

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: October 18, 2010

Address

Country: United States
Legal address: C/O The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street19801 WilmingtonUnited States (US-DE)
Head office: 200 Sidney Street02139 CambridgeUnited States (US-MA)

Identifier

LEI: 549300GMXBE5NUWISF13
Registered: May 28, 2015 at 01:45 AM UTC
Last updated: July 30, 2026 at 05:10 PM UTC
Next renewal: May 12, 2023 at 05:43 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 4885861
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 4885861
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No owner is known to control it

Machine access

REST: https://lei.online/v1/entities/549300GMXBE5NUWISF13This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search